Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
C
Citi Pharma Ltd
KAR:CPHL
Citi Pharma Ltd
KAR:CPHL
Price:
71.86
PKR
-0.42%
Market Closed
Market Cap:
Rs16.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Citi Pharma Ltd
KAR:CPHL
|
PK |
|
Yevropyeyskaya Elyektrotyekhnika PAO
MOEX:EELT
|
RU |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CPHL's stock price target?
Not Available
CPHL does not have any price targets made by Wall Street professionals.
What is the Gross Profit forecast for Citi Pharma Ltd?
Projected CAGR
11%
11%
Over the last 4 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next -3 years is 11%.
What is the Operating Income forecast for Citi Pharma Ltd?
Projected CAGR
14%
14%
Over the last 4 years, the compound annual growth rate for Operating Income has been 29%. The projected CAGR for the next -3 years is 14%.
What is the Pre-Tax Income forecast for Citi Pharma Ltd?
Projected CAGR
11%
11%
Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been 28%. The projected CAGR for the next -3 years is 11%.
What is the Net Income forecast for Citi Pharma Ltd?
Projected CAGR
13%
13%
Over the last 4 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next -3 years is 13%.